QHSLab, Inc. validates the growing need for the Q-Scale, or “Quality of Life” Scale, a digital medicine assessment tool for screening patients who may be suffering from mental and emotional health-related issues. A recent report from the U.S. Preventive Services Task Force (USPSTF) recommended that ALL patients under the age of 65, including children and adolescents aged 8 to 18 years, be screened for depression and anxiety in their primary care appointments. USPSTF made some of the following comments: Both direct and indirect evidence supports depression screening in primary care settings; Screening for anxiety is recommended in adults younger than 65, including those who are pregnant and postpartum, and can help identify anxiety in its early stages; There is clear evidence that treatment for anxiety is beneficial.

QHSLab, Inc. provides primary care physicians (PCPs) and pediatricians with the digital tools to meet these proposed national mental health guidelines. PCPs are on the frontline of healthcare. They are often the first resource seen by patients presenting a mental health concern – and can uncover an undiagnosed mental health condition.

These physicians desperately need efficient, cost-effective, and reliable tools to help them screen for various medical conditions, including mental health concerns. Early detection through digital tools, including the Company's “Q-Scale” or “Quality of Life Assessment,” can improve clinical outcomes and the ability of PCPs to provide the best care for their patients. In addition, digital health and clinical decision support services allow these physicians to generate revenue through a reimbursable service.

QHSLab provides digital health screening that aligns with reimbursement guidelines but also offers a suite of patient education resources through podcasts and other mediums - covering various topics, including exercise, nutrition, curbing addictions, progressive relaxation, and mindfulness exercises. Therefore, the physician can screen, diagnose and provide easy-to-access educational life modification programs to assist patients suffering from mild to moderate anxiety and depression. The QHSLab Q-Scale is a 10-question digital health questionnaire designed to measure psycho-emotional factors in patients who might be at risk of mental health issues.

Five categorical ratings are available for response to each item, ranging from “None of the time” to “All of the time.” If responses to the Q-Scale indicate potential mental health troubles, patients are directed to the Patient Health Questionnaire (PHQ), General Anxiety Disorder (GAD) assessment, and Kessler 6 questions within the assessment to identify their risk of anxiety and depression for further clinical evaluation. Conversely, if responses to the questions categorize the patient as “at risk” for mental health issues, including anxiety or depression, the treating physician will be informed through a simple-to-read report of the need for a more focused evaluation during their encounter with the patient or referral to a specialist. For physicians, the Q-Scale Assessment is a time-saving means of maximizing the benefits of face-to-face office visits while generating additional revenue through reimbursement codes accepted by commercial payors, Medicare and Medicaid, which fulfills a proposed requirement of routine patient care.

From a patient perspective, the Q-Scale Assessment promotes early detection and treatment of conditions potentially related to anxiety or depression and increases the value provided by routine care. Key aspects of the QHSLab Q-Scale product include: The utilization of QHSLab's cloud-based software and technology system scales to allow a virtually unlimited number of user sessions to be activated and integrated into existing physician and healthcare interventions while collecting and compiling relevant, empirical data; The measurement of a patient's responses, identifying early "warning" signs using questions regarding sleep, stress, anxiety, worry, pain, and overall life satisfaction. Patients with high mental health risks are identified for further screening during the same assessment.

Items in the Q-Scale have been deliberately written to emphasize normal psychological functioning in generally healthy patients; therefore, it is a total population screening tool; If responses to the Q-Scale Assessment indicate potential mental health issues, patients are directed to the PHQ, GAD, and Kessler 6 instruments, which are global measures of distress from depressive and anxiety-related symptomology. The treating physician is then alerted to the need for a more focused evaluation during their encounter with the patient or refers the patient for specialist mental health assessment; Patients receive digital “feedback” post-assessment reports and self-management strategies useful in addressing items identified during the assessment.